2001•PubMedRequires access

[Monitoring gene expression profile changes in endometrial cancer using cDNA microarray technology].

Y Meng, Lei Wei, Jianliu Wang

Open publisher page 5 citations

Abstract

OBJECTIVE: To study the difference in gene expression between normal endometrial tissue and endometrial cancer tissue so as to investigate the mechanism of pathogenesis of endometrial cancer. METHODS: The tissues from 30 patients with endometrial cancer and normal endometrial tissues from the same patients were analyzed by cDNA microarray technology (including 588 genes). General RNA was extracted from these tissues and probes were made to be hybridized with cDNA array membrane. The CD147 expressions in normal endometrial tissue and in endometrial cancer tissue were identified by immunohistochemistry. RESULTS: The endometrial cancer associated genes - IRP, Wnt-5A, 5T4 oncofetal antigen precursor, aggrecan core protein precursor, CD147, TIMP-2, were expressed highly. CONCLUSION: cDNA microarray technology can simultaneously monitor the different expressions of genes from two different tissues. CD147 might be useful in assessing the progression and infiltration of endometrial cancer.

About this research paper

What this paper is about

OBJECTIVE: To study the difference in gene expression between normal endometrial tissue and endometrial cancer tissue so as to investigate the mechanism of pathogenesis of endometrial cancer. METHODS: The tissues from 30 patients with endometrial cancer and normal endometrial tissues from the same patients were analyzed by cDNA microarray technology (including 588 genes). General RNA was extracted from these tissues and probes were made to be hybridized with cDNA array membrane. The CD147 expressions in normal endometrial tissue and in endometrial cancer tissue were identified by immunohistochemistry. RESULTS: The endometrial cancer associated genes - IRP, Wnt-5A, 5T4 oncofetal antigen precursor, aggrecan core protein precursor, CD147, TIMP-2, were expressed highly. CONCLUSION: cDNA microarray technology can simultaneously monitor the different expressions of genes from two different tissues. CD147 might be useful in assessing the progression and infiltration of endometrial cancer.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To study the difference in gene expression between normal endometrial tissue and endometrial cancer tissue so as to investigate the mechanism of pathogenesis of endometrial cancer. METHODS: The tissues from 30 patients with endometrial cancer and normal endometrial tissues from the same patients were analyzed by cDNA microarray technology (including 588 genes). General RNA was extracted from these tissues and probes were made to be hybridized with cDNA array membrane. The CD147 expressions in normal endometrial tissue and in endometrial cancer tissue were identified by immunohistochemistry. RESULTS: The endometrial cancer associated genes - IRP, Wnt-5A, 5T4 oncofetal antigen precursor, aggrecan core protein precursor, CD147, TIMP-2, were expressed highly. CONCLUSION: cDNA microarray technology can simultaneously monitor the different expressions of genes from two different tissues. CD147 might be useful in assessing the progression and infiltration of endometrial cancer.

Key concepts: Endometrial cancer, Complementary DNA, Microarray, Tissue microarray, Cancer research, Immunohistochemistry, Biology, Microarray analysis techniques

Related papers

Back to paper searchBrowse research topicsOriginal source
[Monitoring gene expression profile changes in endometrial cancer using cDNA microarray technology]. — Research Paper | ScholarLens